$HALO News Article - Positive Results Announced from Phase 3 OCARINA II Trial Evaluating Roche's OCREVUS (ocrelizumab) with Halozyme's ENHANZE Drug Delivery Technology in Patients with Multiple Sclerosis
https://marketwirenews.com/news-releases/posi...08521.html